{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:54:23Z","timestamp":1777625663453,"version":"3.51.4"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s12276-018-0094-1","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T03:21:51Z","timestamp":1526959311000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["The wide utility of rabbits as models of human diseases"],"prefix":"10.1038","volume":"50","author":[{"given":"Pedro J.","family":"Esteves","sequence":"first","affiliation":[]},{"given":"Joana","family":"Abrantes","sequence":"additional","affiliation":[]},{"given":"Hanna-Mari","family":"Baldauf","sequence":"additional","affiliation":[]},{"given":"Lbachir","family":"BenMohamed","sequence":"additional","affiliation":[]},{"given":"Yuxing","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Neil","family":"Christensen","sequence":"additional","affiliation":[]},{"given":"Javier","family":"Gonz\u00e1lez-Gallego","sequence":"additional","affiliation":[]},{"given":"Lorenzo","family":"Giacani","sequence":"additional","affiliation":[]},{"given":"Jiafen","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Gilla","family":"Kaplan","sequence":"additional","affiliation":[]},{"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[]},{"given":"Katherine L.","family":"Knight","sequence":"additional","affiliation":[]},{"given":"Xiang-Peng","family":"Kong","sequence":"additional","affiliation":[]},{"given":"Dennis K.","family":"Lanning","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"Le Pendu","sequence":"additional","affiliation":[]},{"given":"Ana Lemos","family":"de Matos","sequence":"additional","affiliation":[]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Shuying","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Ana M.","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Sheila","family":"Lukehart","sequence":"additional","affiliation":[]},{"given":"Yukari C.","family":"Manabe","sequence":"additional","affiliation":[]},{"given":"Fabiana","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Grant","family":"McFadden","sequence":"additional","affiliation":[]},{"given":"Ruimin","family":"Pan","sequence":"additional","affiliation":[]},{"given":"Xuwen","family":"Peng","sequence":"additional","affiliation":[]},{"given":"Patricia","family":"de Sousa-Pereira","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Masmudur","family":"Rahman","sequence":"additional","affiliation":[]},{"given":"Natalie","family":"Ruvo\u00ebn-Clouet","sequence":"additional","affiliation":[]},{"given":"Selvakumar","family":"Subbian","sequence":"additional","affiliation":[]},{"given":"Maria Jes\u00fas","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[]},{"given":"Wessel","family":"van der Loo","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Vaine","sequence":"additional","affiliation":[]},{"given":"Laura E.","family":"Via","sequence":"additional","affiliation":[]},{"given":"Shixia","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Rose","family":"Mage","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"94_CR1","first-page":"765","volume":"101","author":"L Pasteur","year":"1885","unstructured":"Pasteur, L. M\u00e9thode pour pr\u00e9venir la rage apr\u00e8s morsure. Comptes rendus Hebd. Des. s\u00e9ances De. l\u2019Acad\u00e9mie Des. Sci. 101, 765\u2013774 (1885).","journal-title":"Comptes rendus Hebd. Des. s\u00e9ances De. l\u2019Acad\u00e9mie Des. Sci."},{"key":"94_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00251-011-0533-9","volume":"63","author":"A Pinheiro","year":"2011","unstructured":"Pinheiro, A. et al. Molecular bases of genetic diversity and evolution of the immunoglobulin heavy chain variable region (IGHV) gene locus in leporids. Immunogenetics 63, 397\u2013408 (2011).","journal-title":"Immunogenetics"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00251-015-0868-8","volume":"68","author":"A Pinheiro","year":"2016","unstructured":"Pinheiro, A. et al. An overview of the lagomorph immune system and its genetic diversity. Immunogenetics 68, 83\u2013107 (2016).","journal-title":"Immunogenetics"},{"key":"94_CR4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/B978-0-12-374279-7.12016-8","volume-title":"Encyclopedia of immunobiology.","author":"RG Mage","year":"2016","unstructured":"Mage, R. G., Pinheiro, A., Lemos de Matos, A. & Esteves, P. J. The immune system of lagomorphs. In: M. J. H. Ratcliffe (ed). Encyclopedia of immunobiology. Vol. 1, (515\u2013525. Elsevier, Amsterdam, Holand, 2016)."},{"key":"94_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/B978-0-12-380920-9.00018-3","volume-title":"The laboratory rabbit, guinea pig, hamster, and other rodents.","author":"TH Burkholder","year":"2012","unstructured":"Burkholder, T. H., Linton, G. F. R., Hoyt, J. & Young, R. The rabbit as an experimental model. In: M. A. Suckow, K. A. Stevens, R. P. Wilson (eds). The laboratory rabbit, guinea pig, hamster, and other rodents. pp. 529\u2013560. (Academic Press, Cambridge, MA, USA, 2012)."},{"key":"94_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2013.06.026","volume":"87","author":"K Mullane","year":"2014","unstructured":"Mullane, K. & Williams, M. Animal models of asthma: reprise or reboot? Biochem. Pharmacol. 87, 131\u2013139 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"94_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcp.2013.06.014","volume":"87","author":"DR Webb","year":"2014","unstructured":"Webb, D. R. Animal models of human disease: inflammation. Biochem. Pharmacol. 87, 121\u2013130 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"94_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/379333a0","volume":"379","author":"D Graur","year":"1996","unstructured":"Graur, D., Duret, L. & Gouy, M. Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature 379, 333\u2013335 (1996).","journal-title":"Nature"},{"key":"94_CR9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1753425915606209","volume":"21","author":"F Neves","year":"2015","unstructured":"Neves, F. et al. Genetic characterization of interleukins (IL-1alpha, IL-1beta, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs. Innate Immun. 21, 787\u2013801 (2015).","journal-title":"Innate Immun."},{"key":"94_CR10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/cyto.1999.0658","volume":"12","author":"HD Perkins","year":"2000","unstructured":"Perkins, H. D., van Leeuwen, B. H., Hardy, C. M. & Kerr, P. J. The complete cDNA sequences of IL-2, IL-4, IL-6 AND IL-10 from the European rabbit (Oryctolagus cuniculus). Cytokine 12, 555\u2013565 (2000).","journal-title":"Cytokine"},{"key":"94_CR11","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1161\/01.CIR.0000164233.09448.B1","volume":"111","author":"J James","year":"2005","unstructured":"James, J. et al. Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation 111, 2339\u20132346 (2005).","journal-title":"Circulation"},{"key":"94_CR12","first-page":"433","volume":"34","author":"J Zschaler","year":"2014","unstructured":"Zschaler, J., Schlorke, D. & Arnhold, J. Differences in innate immune response between man and mouse. Crit. Rev. Immunol. 34, 433\u2013454 (2014).","journal-title":"Crit. Rev. Immunol."},{"key":"94_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2014.09.009","volume":"146","author":"J Fan","year":"2015","unstructured":"Fan, J. et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol. Ther. 146, 104\u2013119 (2015).","journal-title":"Pharmacol. Ther."},{"key":"94_CR14","first-page":"121867","volume":"2014","author":"J Tian","year":"2012","unstructured":"Tian, J. et al. A novel model of atherosclerosis in rabbits using injury to arterial walls induced by ferric chloride as evaluated by optical coherence tomography as well as intravascular ultrasound and histology. J. Biomed. Biotechnol. 2014, 121867 (2012).","journal-title":"J. Biomed. Biotechnol."},{"key":"94_CR15","first-page":"1030","volume":"51","author":"A Jim\u00e9nez-Garc\u00eda","year":"2004","unstructured":"Jim\u00e9nez-Garc\u00eda, A. et al. Intestinal wall damage in simple ileus in rabbits: immune-modulator role of somatostatin. Hepatogastroenterology 51, 1030\u20131036 (2004).","journal-title":"Hepatogastroenterology"},{"key":"94_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/REP-12-0091","volume":"144","author":"B Fischer","year":"2012","unstructured":"Fischer, B., Chavatte-Palmer, P., Viebahn, C., Navarrete Santos, A. & Duranthon, V. Rabbit as a reproductive model for human health. Reproduction 144, 1\u201310 (2012).","journal-title":"Reproduction"},{"key":"94_CR17","first-page":"201","volume-title":"Systemic Lupus Erythematosus.","author":"RG Mage","year":"2012","unstructured":"Mage, R. G. & Rai, G. A rabbit model of systemic lupus erythematosus, useful for studies of neuropsychiatric SLE. In: H. Almoallin (ed). Systemic Lupus Erythematosus. pp. 201\u2013217. (InTech \u2013Open Access Publisher, Rijeka, Croatia, 2012)."},{"key":"94_CR18","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar4156","volume":"15","author":"G Desando","year":"2013","unstructured":"Desando, G. et al. Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Res. Ther. 15, R22 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"94_CR19","first-page":"394730","volume":"2011","author":"SJ Kang","year":"2011","unstructured":"Kang, S. J. & Grossniklaus, H. E. Rabbit model of retinoblastoma. J. Biomed. Biotechnol. 2011, 394730 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"94_CR20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/JAD-2007-11313","volume":"11","author":"DS Woodruff-Pak","year":"2007","unstructured":"Woodruff-Pak, D. S., Agelan, A. & Del Valle, L. A rabbit model of Alzheimer\u2019s disease: valid at neuropathological, cognitive, and therapeutic levels. J. Alzheimers Dis. 11, 371\u2013383 (2007).","journal-title":"J. Alzheimers Dis."},{"key":"94_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1084\/jem.20041849","volume":"201","author":"KJ Rhee","year":"2005","unstructured":"Rhee, K. J. et al. Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissue. J. Exp. Med. 201, 55\u201362 (2005).","journal-title":"J. Exp. Med."},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.dci.2005.06.017","volume":"30","author":"RG Mage","year":"2006","unstructured":"Mage, R. G., Lanning, D. & Knight, K. L. B cell and antibody repertoire development in rabbits: the requirement of gut-associated lymphoid tissues. Dev. Comp. Immunol. 30, 137\u2013153 (2006).","journal-title":"Dev. Comp. Immunol."},{"key":"94_CR23","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1002\/j.1460-2075.1989.tb08587.x","volume":"8","author":"RC Burnett","year":"1989","unstructured":"Burnett, R. C., Hanly, W. C., Zhai, S. K. & Knight, K. L. The IgA heavy-chain gene family in rabbit: cloning and sequence analysis of 13 C alpha genes. EMBO J. 8, 4041\u20134047 (1989).","journal-title":"EMBO J."},{"key":"94_CR24","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.4049\/jimmunol.178.12.7943","volume":"178","author":"L Abi-Rached","year":"2007","unstructured":"Abi-Rached, L., Dorighi, K., Norman, P. J., Yawata, M. & Parham, P. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins. J. Immunol. 178, 7943\u20137954 (2007).","journal-title":"J. Immunol."},{"key":"94_CR25","doi-asserted-by":"crossref","first-page":"e73934","DOI":"10.1371\/journal.pone.0073934","volume":"8","author":"A Pinheiro","year":"2013","unstructured":"Pinheiro, A., Woof, J. M., Abi-Rached, L., Parham, P. & Esteves, P. J. Computational analyses of an evolutionary arms race between mammalian immunity mediated by immunoglobulin A and its subversion by bacterial pathogens. PLoS ONE 8, e73934 (2013).","journal-title":"PLoS ONE"},{"key":"94_CR26","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2165\/00003495-200969110-00007","volume":"69","author":"ED Deeks","year":"2009","unstructured":"Deeks, E. D. & Keating, G. M. Rabbit anti-thymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs 69, 1483\u20131512 (2009).","journal-title":"Drugs"},{"key":"94_CR27","doi-asserted-by":"crossref","first-page":"e21045","DOI":"10.1371\/journal.pone.0021045","volume":"6","author":"T Flisikowska","year":"2011","unstructured":"Flisikowska, T. et al. Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS ONE 6, e21045 (2011).","journal-title":"PLoS ONE"},{"key":"94_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.23","volume":"49","author":"J Weber","year":"2017","unstructured":"Weber, J., Peng, H. & Rader, C. From rabbit antibody repertoires to rabbit monoclonal antibodies. Exp. Mol. Med. 49, e305 (2017).","journal-title":"Exp. Mol. Med."},{"key":"94_CR29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/19420862.2017.1289302","volume":"9","author":"YF Zhang","year":"2017","unstructured":"Zhang, Y. F. & Ho, M. Humanization of rabbit monoclonal antibodies via grafting combined Kabat\/IMGT\/Paratome complementarity-determining regions: rationale and examples. MAbs 9, 419\u2013429 (2017).","journal-title":"MAbs"},{"key":"94_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/IDR.S47305","volume":"7","author":"CE Kummerfeldt","year":"2014","unstructured":"Kummerfeldt, C. E. Raxibacumab: potential role in the treatment of inhalational anthrax. Infect. Drug Resist. 7, 101\u2013109 (2014).","journal-title":"Infect. Drug Resist."},{"key":"94_CR31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40265-016-0577-0","volume":"76","author":"SL Greig","year":"2016","unstructured":"Greig, S. L. Obiltoxaximab: first global approval. Drugs 76, 823\u2013830 (2016).","journal-title":"Drugs"},{"key":"94_CR32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00251-006-0095-4","volume":"58","author":"C Carmo","year":"2006","unstructured":"Carmo, C., Esteves, P. J., Ferrand, N. & van der Loo, W. Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extra cellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species. Immunogenetics 58, 494\u2013501 (2006).","journal-title":"Immunogenetics"},{"key":"94_CR33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10592-009-9990-1","volume":"12","author":"J Abrantes","year":"2011","unstructured":"Abrantes, J. et al. A shared unusual genetic change at the chemokine receptor type 5 between Oryctolagus, Bunolagus and Pentalagus. Conserv. Genet 12, 325\u2013330 (2011).","journal-title":"Conserv. Genet"},{"key":"94_CR34","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1074\/jbc.M115.640169","volume":"290","author":"G Lau","year":"2015","unstructured":"Lau, G., Labrecque, J., Metz, M., Vaz, R. & Fricker, S. P. Specificity for a CCR5 inhibitor is conferred by a single amino acid residue ROLE OF ILE198. J. Biol. Chem. 290, 11041\u201311051 (2015).","journal-title":"J. Biol. Chem."},{"key":"94_CR35","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.4049\/jimmunol.160.8.4034","volume":"160","author":"P Proost","year":"1998","unstructured":"Proost, P. et al. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2 (6\u201376) as a natural chemokine inhibitor. J. Immunol. 160, 4034\u20134041 (1998).","journal-title":"J. Immunol."},{"key":"94_CR36","volume":"13","author":"W Loo van der","year":"2012","unstructured":"van der Loo, W., Afonso, S., de Matos, A. L., Abrantes, J. & Esteves, P. J. Pseudogenization of the MCP 2\/CCL8 Chemokine Gene in European Rabbit (genus Oryctolagus), but not in species of Cottontail Rabbit (Sylvilagus) and Hare (Lepus). BMC Genet. 13, 72 (2012).","journal-title":"BMC Genet."},{"key":"94_CR37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00239-016-9747-7","volume":"83","author":"W Loo van der","year":"2016","unstructured":"van der Loo, W. et al. Adaptive gene loss? Tracing back the pseudogenization of the Rabbit CCL8 chemokine. J. Mol. Evolution 83, 12\u201325 (2016).","journal-title":"J. Mol. Evolution"},{"key":"94_CR38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1297-9716-43-12","volume":"43","author":"J Abrantes","year":"2012","unstructured":"Abrantes, J., van der Loo, W., Le Pendu, J. & Esteves, P. J. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet. Res. 43, 12 (2012).","journal-title":"Vet. Res."},{"key":"94_CR39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.antiviral.2012.01.009","volume":"93","author":"PJ Kerr","year":"2012","unstructured":"Kerr, P. J. Myxomatosis in Australia and Europe: a model for emerging infectious diseases. Antivir. Res. 93, 387\u2013415 (2012).","journal-title":"Antivir. Res."},{"key":"94_CR40","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/v7031020","volume":"7","author":"PJ Kerr","year":"2015","unstructured":"Kerr, P. J. et al. Myxoma virus and the Leporipoxviruses: an evolutionary paradigm. Viruses 7, 1020\u20131061 (2015).","journal-title":"Viruses"},{"key":"94_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/vr.d697","volume":"168","author":"G Gall-Recul\u00e9 Le","year":"2011","unstructured":"Le Gall-Recul\u00e9, G. et al. Detection of a new variant of rabbit haemorrhagic disease virus in France. Vet. Rec. 168, 137\u2013138 (2011).","journal-title":"Vet. Rec."},{"key":"94_CR42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1099\/vir.0.000070","volume":"96","author":"AM Lopes","year":"2015","unstructured":"Lopes, A. M. et al. Full genomic analysis of new variant Rabbit Hemorrhagic Disease Virus (RHDVb) revealed multiple recombination events. J. Gen. Virol. 96, 1309\u20131319 (2015).","journal-title":"J. Gen. Virol."},{"key":"94_CR43","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1128\/JVI.03488-12","volume":"87","author":"WM Chan","year":"2013","unstructured":"Chan, W. M. et al. Myxoma and vaccinia viruses bind differentially to human leukocytes. J. Virol. 87, 4445\u20134460 (2013).","journal-title":"J. Virol."},{"key":"94_CR44","first-page":"119","volume":"1","author":"WM Chan","year":"2014","unstructured":"Chan, W. M. & McFadden, G. Oncolytic poxviruses. Annu Rev. Virol. 1, 119\u2013141 (2014).","journal-title":"Annu Rev. Virol."},{"key":"94_CR45","first-page":"31","volume":"4","author":"CL Lilly","year":"2017","unstructured":"Lilly, C. L. et al. Ex-vivo oncolytic virotherapy with myxoma virus arms multiple allogeneic bone marrow transplant leukocytes to enhance graft versus tumor. Mol. Ther. 4, 31\u201340 (2017).","journal-title":"Mol. Ther."},{"key":"94_CR46","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.74.24.11950-11954.2000","volume":"74","author":"N Ruvo\u00ebn-Clouet","year":"2000","unstructured":"Ruvo\u00ebn-Clouet, N., Gani\u00e8re, J. P., Andr\u00e9-Fontaine, G., Blanchard, D. & Le Pendu, J. Binding of rabbit hemorrhagic disease vrus to antigens of the ABH histo-blood group family. J. Virol. 74, 11950\u201311954 (2000).","journal-title":"J. Virol."},{"key":"94_CR47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(14)70767-4","volume":"14","author":"SM Ahmed","year":"2014","unstructured":"Ahmed, S. M. et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect. Dis. 14, 725\u2013730 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"94_CR48","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/erm.2014.2","volume":"16","author":"M Tan","year":"2014","unstructured":"Tan, M. & Jiang, X. Histo-blood group antigens: a common nich for norovirus and rotavirus. Expert. Rev. Mol. Med. 16, e5 (2014).","journal-title":"Expert. Rev. Mol. Med."},{"key":"94_CR49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.1757","volume":"23","author":"N Ruv\u00f6en-Clouet","year":"2013","unstructured":"Ruv\u00f6en-Clouet, N., Belliot, G. & Le Pendu, J. Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. Rev. Med. Virol. 23, 355\u2013366 (2013).","journal-title":"Rev. Med. Virol."},{"key":"94_CR50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coviro.2014.06.001","volume":"7","author":"J Pendu Le","year":"2014","unstructured":"Le Pendu, J., Nystrom, K. & Ruvoen-Clouet, N. Host-pathogen co-evolution and glycan interactions. Curr. Opin. Virol. 7, 88\u201394 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"94_CR51","doi-asserted-by":"crossref","first-page":"e1002188","DOI":"10.1371\/journal.ppat.1002188","volume":"7","author":"K Nystr\u00f6m","year":"2011","unstructured":"Nystr\u00f6m, K. et al. Histo-blood group antigens act as attachment factors of rabbit hemorrhagic disease virus infection in a virus strain-dependent manner. PLoS Pathog. 7, e1002188 (2011).","journal-title":"PLoS Pathog."},{"key":"94_CR52","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3748\/wjg.15.3086","volume":"15","author":"MJ Tu\u00f1\u00f3n","year":"2009","unstructured":"Tu\u00f1\u00f3n, M. J., Alvarez, M., Culebras, J. M. & Gonz\u00e1lez-Gallego, J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J. Gastroenterol. 15, 3086\u20133098 (2009).","journal-title":"World J. Gastroenterol."},{"key":"94_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1297-9716-45-15","volume":"45","author":"D Vallejo","year":"2014","unstructured":"Vallejo, D. et al. Autophagic response in the rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure. Vet. Res. 45, 15 (2014).","journal-title":"Vet. Res."},{"key":"94_CR54","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1128\/JVI.05725-11","volume":"85","author":"MJ Tu\u00f1\u00f3n","year":"2011","unstructured":"Tu\u00f1\u00f3n, M. J. et al. Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin. J. Virol. 85, 13124\u201313132 (2011).","journal-title":"J. Virol."},{"key":"94_CR55","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/jcp.25431","volume":"231","author":"L Booth","year":"2016","unstructured":"Booth, L. et al. AR-12 inhibits multiple chaperones concomitant with stimulating autophagosome formation collectively preventing virus replication. J. Cell Physiol. 231, 2286\u20132302 (2016).","journal-title":"J. Cell Physiol."},{"key":"94_CR56","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10495-006-0090-0","volume":"11","author":"B San-Miguel","year":"2006","unstructured":"San-Miguel, B., Alvarez, M., Culebras, J. M., Gonz\u00e1lez-Gallego, J. & Tu\u00f1\u00f3n, M. J. N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure. Apoptosis 11, 1945\u20131957 (2006).","journal-title":"Apoptosis"},{"key":"94_CR57","first-page":"193","volume":"49","author":"I Crespo","year":"2010","unstructured":"Crespo, I. et al. Melatonin prevents the decreased activity of antioxidant enzymes and activates nuclear erythroid 2-related factor 2 signaling in an animal model of fulminant hepatic failure of viral origin. J. Pineal Res. 49, 193\u2013200 (2010).","journal-title":"J. Pineal Res."},{"key":"94_CR58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jpi.12335","volume":"61","author":"I Crespo","year":"2016","unstructured":"Crespo, I. et al. Melatonin inhibits the sphingosine kinase 1\/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin. J. Pineal Res. 61, 168\u2013176 (2016).","journal-title":"J. Pineal Res."},{"key":"94_CR59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1297-9716-44-81","volume":"44","author":"G Gall-Recul\u00e9 Le","year":"2013","unstructured":"Le Gall-Recul\u00e9, G. et al. Emergence of a new lagovirus related to rabbit hemorrhagic disease virus. Vet. Res. 44, 81 (2013).","journal-title":"Vet. Res."},{"key":"94_CR60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/jama.1913.04340020016005","volume":"60","author":"HJ Nichols","year":"1913","unstructured":"Nichols, H. J. & Hough, W. H. Demonstration of Spirochaeta pallida in the cerebrospinal fluid. JAMA 60, 108\u2013110 (1913).","journal-title":"JAMA"},{"key":"94_CR61","first-page":"1","volume":"32","author":"HJ Magnuson","year":"1948","unstructured":"Magnuson, H. J., Eagle, H. & Fleischman, R. The minimal infectious inoculum of Spirochaeta pallida (Nichols Strain), and a consideration of its rate of multiplication in vivo. Am. J. Syph. 32, 1\u201318 (1948).","journal-title":"Am. J. Syph."},{"key":"94_CR62","volume-title":"Biology of the Treponematoses.","author":"TB Turner","year":"1957","unstructured":"Turner, T. B. & Hollander, D. H. Biology of the Treponematoses.. (World Health Organization, Geneva, Switzerland, 1957)."},{"key":"94_CR63","first-page":"203","volume":"24","author":"S Sell","year":"1983","unstructured":"Sell, S. & Norris, S. J. The biology, pathology, and immunology of syphilis. Int. Rev. Exp. Pathol. 24, 203\u2013276 (1983).","journal-title":"Int. Rev. Exp. Pathol."},{"key":"94_CR64","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1038\/ncomms14273","volume":"8","author":"KV Lithgow","year":"2017","unstructured":"Lithgow, K. V. et al. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum. Nat. Commun. 8, 14273 (2017).","journal-title":"Nat. Commun."},{"key":"94_CR65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1139\/m85-142","volume":"31","author":"TJ Fitzgerald","year":"1985","unstructured":"Fitzgerald, T. J. Experimental congenital syphilis in rabbits. Can. J. Microbiol. 31, 757\u2013762 (1985).","journal-title":"Can. J. Microbiol."},{"key":"94_CR66","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/IAI.61.11.4743-4749.1993","volume":"61","author":"MK Froberg","year":"1993","unstructured":"Froberg, M. K., Fitzgerald, T. J., Hamilton, T. R., Hamilton, B. & Zarabi, M. Pathology of congenital syphilis in rabbits. Infect. Immun. 61, 4743\u20134749 (1993).","journal-title":"Infect. Immun."},{"key":"94_CR67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/426510","volume":"191","author":"LC Tantalo","year":"2005","unstructured":"Tantalo, L. C., Lukehart, S. A. & Marra, C. M. Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model. J. Infect. Dis. 191, 75\u201380 (2005).","journal-title":"J. Infect. Dis."},{"key":"94_CR68","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/iai.28.3.909-913.1980","volume":"28","author":"RF Schell","year":"1980","unstructured":"Schell, R. F., LeFrock, J. L., Chan, J. K. & Bagasra, O. LSH hamster model of syphilitic infection. Infect. Immun. 28, 909\u2013913 (1980).","journal-title":"Infect. Immun."},{"key":"94_CR69","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/IAI.57.9.2900-2902.1989","volume":"57","author":"K Wicher","year":"1989","unstructured":"Wicher, K., Miller, J. N., Urquhart, A. W. & Wicher, V. Treponema pallidum-immobilizing antibodies in guinea pig experimental syphilis. Infect. Immun. 57, 2900\u20132902 (1989).","journal-title":"Infect. Immun."},{"key":"94_CR70","first-page":"59","volume":"32","author":"B Gueft","year":"1948","unstructured":"Gueft, B. & Rosahn, P. D. Experimental mouse syphilis, a critical review of the literature. Am. J. Syph. 32, 59\u201388 (1948).","journal-title":"Am. J. Syph."},{"key":"94_CR71","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.0902788","volume":"184","author":"L Giacani","year":"2010","unstructured":"Giacani, L. et al. Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis. J. Immunol. 184, 3822\u20133829 (2010).","journal-title":"J. Immunol."},{"key":"94_CR72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/OLQ.0000000000000486","volume":"43","author":"BJ Molini","year":"2016","unstructured":"Molini, B. J. et al. Macrolide resistance in Treponema pallidum correlates with 23S rDNA mutations in recently isolated clinical strains. Sex. Transm. Dis. 43, 579\u2013583 (2016).","journal-title":"Sex. Transm. Dis."},{"key":"94_CR73","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.vaccine.2013.09.053","volume":"32","author":"CE Cameron","year":"2014","unstructured":"Cameron, C. E. & Lukehart, S. A. Current status of syphilis vaccine development: need, challenges, prospects. Vaccine 32, 1602\u20131609 (2014).","journal-title":"Vaccine"},{"key":"94_CR74","first-page":"221","volume":"19","author":"R Koch","year":"1882","unstructured":"Koch, R. Die aetiologie der tuberkulose. Berl. Klin. Wochenschr. 19, 221\u2013230 (1882).","journal-title":"Berl. Klin. Wochenschr."},{"key":"94_CR75","doi-asserted-by":"crossref","DOI":"10.4159\/harvard.9780674420960","volume-title":"Resistance to tuberculosis: Experimental studies in native and acquired defensive mechanisms.","author":"MB Lurie","year":"1964","unstructured":"Lurie, M. B. Resistance to tuberculosis: Experimental studies in native and acquired defensive mechanisms. (Harvard University Press, Cambridge, MA, USA, 1964)."},{"key":"94_CR76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vetimm.2007.11.006","volume":"122","author":"S Mendez","year":"2008","unstructured":"Mendez, S. et al. Susceptibility to tuberculosis: composition of tuberculous granulomas in Thorbecke and outbred New Zealand White rabbits. Vet. Immunol. Immunopathol. 122, 167\u2013174 (2008).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"94_CR77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1201\/EBK1439835272-10","volume-title":"A Colour Atlas of comparative pulmonary tuberculosis histopathology.","author":"G Kaplan","year":"2010","unstructured":"Kaplan, G. & Tsenova, L. Pulmonary tuberculosis in the rabbit. In: F. J. Leong, V. Dartois, T. Dick (eds). A Colour Atlas of comparative pulmonary tuberculosis histopathology. pp. 107\u2013130. (CRC Press, Boca Raton, FL, USA, 2010)."},{"key":"94_CR78","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/9783527611614.ch32","volume-title":"Handbook of tuberculosis.","author":"JL Flynn","year":"2008","unstructured":"Flynn, J. L., Tsenova, L., Izzo, A. & Kaplan, G. Experimental animal models of tuberculosis. In: S. H. E. Kaufmann, W. J. Britton (eds). Handbook of tuberculosis. pp. 389\u2013426. (Wiley-VCH Verlag GmbH & Co, Weinheim, Germany, 2008)."},{"key":"94_CR79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tube.2007.10.006","volume":"88","author":"YC Manabe","year":"2008","unstructured":"Manabe, Y. C. et al. The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis 88, 187\u2013196 (2008).","journal-title":"Tuberculosis"},{"key":"94_CR80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7883\/yoken.JJID.2014.147","volume":"68","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Establishment of a rabbit model of spinal tuberculosis using Mycobacterium tuberculosis strain H37Rv. Jpn. J. Infect. Dis. 68, 89\u201397 (2015).","journal-title":"Jpn. J. Infect. Dis."},{"key":"94_CR81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1079\/9781780643960.0402","volume-title":"Tuberculosis, leprosy and mycobacterial diseases of man and animals: The many hosts of mycobacteria.","author":"S Subbian","year":"2015","unstructured":"Subbian, S., Karakousis, P. & Kaplan, G. Rabbit model of mycobacterial diseases. In: H. Mukundan, M. A. Chambers, R. W. Waters, M. H. Larsen (eds). Tuberculosis, leprosy and mycobacterial diseases of man and animals: The many hosts of mycobacteria. pp. 402\u2013418. (CABI, Oxfordshire, UK, 2015)."},{"key":"94_CR82","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.vaccine.2006.11.024","volume":"25","author":"L Tsenova","year":"2007","unstructured":"Tsenova, L. et al. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25, 5126\u20135132 (2007).","journal-title":"Vaccine"},{"key":"94_CR83","first-page":"149","volume-title":"Tuberculosis: pathogenesis, protection and control.","author":"AJ Dannenberg","year":"1994","unstructured":"Dannenberg, A. J. Rabbit model of tuberculosis. In: B. R. Bloom (ed). Tuberculosis: pathogenesis, protection and control. pp. 149\u2013156. (ASM Press, Washington, DC, USA, 1994)."},{"key":"94_CR84","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tube.2005.09.001","volume":"86","author":"KL Helke","year":"2006","unstructured":"Helke, K. L., Mankowski, J. L. & Manabe, Y. C. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis 86, 337\u2013348 (2006).","journal-title":"Tuberculosis"},{"key":"94_CR85","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","volume":"76","author":"LE Via","year":"2008","unstructured":"Via, L. E. et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76, 2333\u20132340 (2008).","journal-title":"Infect. Immun."},{"key":"94_CR86","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1128\/IAI.71.10.6004-6011.2003","volume":"71","author":"YC Manabe","year":"2003","unstructured":"Manabe, Y. C. et al. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 71, 6004\u20136011 (2003).","journal-title":"Infect. Immun."},{"key":"94_CR87","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1128\/AAC.00531-12","volume":"56","author":"LE Via","year":"2012","unstructured":"Via, L. E. et al. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(1)(8)F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. Antimicrob. Agents Chemother. 56, 4391\u20134402 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94_CR88","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.05208-11","volume":"56","author":"MC Kjellsson","year":"2012","unstructured":"Kjellsson, M. C. et al. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. Antimicrob. Agents Chemother. 56, 446\u2013457 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94_CR89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jor.23236","volume":"35","author":"P Liu","year":"2017","unstructured":"Liu, P., Jiang, H., Li, S., Lin, Z. & Jiang, J. Determination of anti-tuberculosis drug concentration and distribution from sustained release microspheres in the vertebrae of a spinal tuberculosis rabbit model. J. Orthop. Res. 35, 200\u2013208 (2017).","journal-title":"J. Orthop. Res."},{"key":"94_CR90","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","volume":"21","author":"B Prideaux","year":"2015","unstructured":"Prideaux, B. et al. The association between sterilizing activity and drug distribution into tuberculosis. Nat. Med. 21, 1223\u20131227 (2015).","journal-title":"Nat. Med."},{"key":"94_CR91","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","volume":"16","author":"A Zumla","year":"2016","unstructured":"Zumla, A. et al. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect. Dis. 16, e47\u2013e63 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"94_CR92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajpath.2011.03.039","volume":"179","author":"S Subbian","year":"2011","unstructured":"Subbian, S. et al. Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. Am. J. Pathol. 179, 289\u2013301 (2011).","journal-title":"Am. J. Pathol."},{"key":"94_CR93","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1424563112","volume":"112","author":"M Datta","year":"2015","unstructured":"Datta, M. et al. Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc. Natl Acad. Sci. USA 112, 1827\u20131832 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"94_CR94","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/CMR.00005-10","volume":"23","author":"AM Dannenberg Jr.","year":"2010","unstructured":"Dannenberg, A. M. Jr. Perspectives on clinical and preclinical testing of new tuberculosis vaccines. Clin. Microbiol. Rev. 23, 781\u2013794 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"94_CR95","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CDLI.5.6.871-881.1998","volume":"5","author":"PJ Converse","year":"1998","unstructured":"Converse, P. J. et al. Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clin. Diagn. Lab. Immunol. 5, 871\u2013881 (1998).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"94_CR96","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/JVI.69.6.3959-3963.1995","volume":"69","author":"F Breitburd","year":"1995","unstructured":"Breitburd, F. et al. Immunization with virus like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69, 3959\u20133963 (1995).","journal-title":"J. Virol."},{"key":"94_CR97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/095632020501600602","volume":"16","author":"ND Christensen","year":"2005","unstructured":"Christensen, N. D. Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies. Antivir. Chem. Chemother. 16, 355\u2013362 (2005).","journal-title":"Antivir. Chem. Chemother."},{"key":"94_CR98","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.virol.2006.08.045","volume":"358","author":"J Hu","year":"2007","unstructured":"Hu, J., Cladel, N. M., Balogh, K., Budgeon, L. & Christensen, N. D. Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo. Virology 358, 384\u2013390 (2007).","journal-title":"Virology"},{"key":"94_CR99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2011.03.019","volume":"414","author":"GA Maglennon","year":"2011","unstructured":"Maglennon, G. A., McIntosh, P. & Doorbar, J. Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 414, 153\u2013163 (2011).","journal-title":"Virology"},{"key":"94_CR100","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.4049\/jimmunol.177.11.8037","volume":"177","author":"J Hu","year":"2006","unstructured":"Hu, J. et al. An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection. J. Immunol. 177, 8037\u20138045 (2006).","journal-title":"J. Immunol."},{"key":"94_CR101","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1128\/JVI.74.21.9868-9877.2000","volume":"74","author":"PD Bieniasz","year":"2000","unstructured":"Bieniasz, P. D. & Cullen, B. R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74, 9868\u20139877 (2000).","journal-title":"J. Virol."},{"key":"94_CR102","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.293.5532.1034","volume":"293","author":"J Cohen","year":"2001","unstructured":"Cohen, J. Building a small-animal model for AIDS, block by block. Science 293, 1034\u20131036 (2001).","journal-title":"Science"},{"key":"94_CR103","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1084\/jem.20011549","volume":"195","author":"OT Keppler","year":"2002","unstructured":"Keppler, O. T. et al. Progress toward a human CD4\/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 195, 719\u2013736 (2002).","journal-title":"J. Exp. Med."},{"key":"94_CR104","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-6-2","volume":"6","author":"N Michel","year":"2009","unstructured":"Michel, N. et al. Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology 6, 2 (2009).","journal-title":"Retrovirology"},{"key":"94_CR105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1600-0854.2006.00449.x","volume":"7","author":"T Cutino-Moguel","year":"2006","unstructured":"Cutino-Moguel, T. & Fassati, A. A phenotypic recessive, post-entry block in rabbit cells that results in aberrant trafficking of HIV-1. Traffic 7, 978\u2013992 (2006).","journal-title":"Traffic"},{"key":"94_CR106","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1128\/JVI.01468-07","volume":"81","author":"T Schaller","year":"2007","unstructured":"Schaller, T., Hue, S. & Towers, G. J. An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J. Virol. 81, 11713\u201311721 (2007).","journal-title":"J. Virol."},{"key":"94_CR107","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1128\/JVI.01607-10","volume":"84","author":"HM Tervo","year":"2010","unstructured":"Tervo, H. M. & Keppler, O. T. High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier. J. Virol. 84, 12300\u201312314 (2010).","journal-title":"J. Virol."},{"key":"94_CR108","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2009.01.009","volume":"5","author":"C Goffinet","year":"2009","unstructured":"Goffinet, C. et al. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5, 285\u2013297 (2009).","journal-title":"Cell Host Microbe"},{"key":"94_CR109","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1093\/nar\/gkn802","volume":"36","author":"T Ikeda","year":"2008","unstructured":"Ikeda, T. et al. The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res. 36, 6859\u20136871 (2008).","journal-title":"Nucleic Acids Res."},{"key":"94_CR110","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1371\/journal.pone.0002035","volume":"3","author":"JX Zhang","year":"2008","unstructured":"Zhang, J. X., Diehl, G. E. & Littman, D. R. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS ONE 3, e2035 (2008).","journal-title":"PLoS ONE"},{"key":"94_CR111","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1128\/JVI.72.7.5728-5734.1998","volume":"72","author":"RF Speck","year":"1998","unstructured":"Speck, R. F. et al. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection. J. Virol. 72, 5728\u20135734 (1998).","journal-title":"J. Virol."},{"key":"94_CR112","volume":"6","author":"R Guo","year":"2016","unstructured":"Guo, R. et al. Generation and evaluation of Myostatin knock-out rabbits and goats using CRISPR\/Cas9 system. Sci. Rep. 6, 29855 (2016).","journal-title":"Sci. Rep."},{"key":"94_CR113","volume":"6","author":"D Yang","year":"2016","unstructured":"Yang, D. et al. Identification and characterization of rabbit ROSA26 for gene knock-in and stable reporter gene expression. Sci. Rep. 6, 25161 (2016).","journal-title":"Sci. Rep."},{"key":"94_CR114","doi-asserted-by":"crossref","first-page":"JVI.01957","DOI":"10.1128\/JVI.01957-17","volume":"92","author":"A Torrents de la Pe\u00f1a","year":"2018","unstructured":"Torrents de la Pe\u00f1a, A. et al. Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations. J. Virol. 92, JVI.01957\u201317 (2018).","journal-title":"J. Virol."},{"key":"94_CR115","doi-asserted-by":"crossref","first-page":"aac4223","DOI":"10.1126\/science.aac4223","volume":"349","author":"RW Sanders","year":"2015","unstructured":"Sanders, R. W. et al. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349, aac4223 (2015).","journal-title":"Science"},{"key":"94_CR116","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.virol.2006.10.032","volume":"360","author":"S Beddows","year":"2007","unstructured":"Beddows, S. et al. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1gp140, trimeric cleavage-defective gp140 and monomeric gp120. Virology 360, 329\u2013340 (2007).","journal-title":"Virology"},{"key":"94_CR117","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.0608635104","volume":"104","author":"PF Zhang","year":"2007","unstructured":"Zhang, P. F. et al. Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization. Proc. Natl Acad. Sci. Usa. 104, 10193\u201310198 (2007).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"94_CR118","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1128\/JVI.77.5.3119-3130.2003","volume":"77","author":"M Dong","year":"2003","unstructured":"Dong, M. et al. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. J. Virol. 77, 3119\u20133130 (2003).","journal-title":"J. Virol."},{"key":"94_CR119","volume":"8","author":"DW Kulp","year":"2017","unstructured":"Kulp, D. W. et al. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. Nat. Commun. 8, 1655 (2017).","journal-title":"Nat. Commun."},{"key":"94_CR120","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1128\/JVI.02536-06","volume":"81","author":"M Law","year":"2007","unstructured":"Law, M., Cardoso, R. M., Wilson, I. A. & Burton, D. R. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. J. Virol. 81, 4272\u20134285 (2007).","journal-title":"J. Virol."},{"key":"94_CR121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/viro.1997.8478","volume":"230","author":"JFL Richmond","year":"1997","unstructured":"Richmond, J. F. L. et al. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. Virology 230, 265\u2013274 (1997).","journal-title":"Virology"},{"key":"94_CR122","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/aid.1998.14.151","volume":"14","author":"S Lu","year":"1998","unstructured":"Lu, S. et al. Immunogenicity of DNA vaccines expressing human immunodeficiency virus type-1 envelope glycoprotein with and without deletions in the V1\/2 and V3 regions. AIDS Res. Hum. Retrovir. 14, 151\u2013155 (1998).","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"94_CR123","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1128\/JVI.79.12.7933-7937.2005","volume":"79","author":"S Wang","year":"2005","unstructured":"Wang, S. et al. Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1. J. Virol. 79, 7933\u20137937 (2005).","journal-title":"J. Virol."},{"key":"94_CR124","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1128\/JVI.00562-08","volume":"82","author":"M Vaine","year":"2008","unstructured":"Vaine, M. et al. Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination. J. Virol. 82, 7369\u20137378 (2008).","journal-title":"J. Virol."},{"key":"94_CR125","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.vaccine.2010.02.006","volume":"28","author":"M Vaine","year":"2010","unstructured":"Vaine, M., Wang, S., Hackett, A., Arthos, J. & Lu, S. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. Vaccine 28, 2999\u20133007 (2010).","journal-title":"Vaccine"},{"key":"94_CR126","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1128\/JVI.00081-11","volume":"85","author":"M Vaine","year":"2011","unstructured":"Vaine, M. et al. Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates. J. Virol. 85, 4927\u20134936 (2011).","journal-title":"J. Virol."},{"key":"94_CR127","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1128\/JVI.00837-13","volume":"87","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design. J. Virol. 87, 10232\u201310243 (2013).","journal-title":"J. Virol."},{"key":"94_CR128","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.1128\/JVI.00843-13","volume":"87","author":"R Pan","year":"2013","unstructured":"Pan, R. et al. Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1 infected humans. J. Virol. 87, 10221\u201310231 (2013).","journal-title":"J. Virol."},{"key":"94_CR129","first-page":"e44","volume":"4","author":"R Pan","year":"2015","unstructured":"Pan, R. et al. Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding. Emerg. Microb. Infect. 4, e44 (2015).","journal-title":"Emerg. Microb. Infect."},{"key":"94_CR130","first-page":"e33","volume":"5","author":"S Liu","year":"2016","unstructured":"Liu, S., Wang, S. & Lu, S. DNA immunization as a technology platform for monoclonal antibody induction. Emerg. Microb. Infect. 5, e33 (2016).","journal-title":"Emerg. Microb. Infect."},{"key":"94_CR131","first-page":"e01793","volume":"91","author":"R Srivastava","year":"2017","unstructured":"Srivastava, R. et al. Human asymptomatic epitopes identified from the herpes simplex virus tegument protein vp13\/14 (ul47) preferentially recall polyfunctional effector memory cd44high cd62llow cd8+ tem cells and protect humanized hla-a*02:01 transgenic mice against ocular herpesvirus infection. J. Virol. 91, e01793\u201316 (2017).","journal-title":"J. Virol."},{"key":"94_CR132","first-page":"e00278","volume":"91","author":"R Srivastava","year":"2017","unstructured":"Srivastava, R. et al. CXCL10\/CXCR3-dependent mobilization of hsv-specific cd8+ tem and cd8+ trm cells within infected tissues allows efficient protection against recurrent herpes infection and disease. J. Virol. 91, e00278\u201317 (2017).","journal-title":"J. Virol."},{"key":"94_CR133","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/02713683.2016.1252405","volume":"42","author":"AB Nesburn","year":"2017","unstructured":"Nesburn, A. B. & BenMohamed, L. A Tribute to Professor Steven L. Wechsler (1948-2016): The man and the scientist. Curr. Eye Res. 42, 161\u2013162 (2017).","journal-title":"Curr. Eye Res."},{"key":"94_CR134","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10753-016-0449-5","volume":"40","author":"A Nalbandian","year":"2017","unstructured":"Nalbandian, A. et al. Activation of the NLRP3 inflammasome is associated with valosin-containing protein myopathy. Inflammation 40, 21\u201341 (2017).","journal-title":"Inflammation"},{"key":"94_CR135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.1700145","volume":"199","author":"AA Khan","year":"2017","unstructured":"Khan, A. A. et al. Bolstering the number and function of HSV-1-specific CD8+ effector memory T cells and tissue-resident memory T cells in latently infected trigeminal ganglia reduces recurrent ocular herpes infection and disease. J. Immunol. 199, 186\u2013203 (2017).","journal-title":"J. Immunol."},{"key":"94_CR136","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1016\/j.vaccine.2011.06.083","volume":"29","author":"G Dasgupta","year":"2011","unstructured":"Dasgupta, G. & BenMohamed, L. Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates? Vaccine 29, 5824\u20135836 (2011).","journal-title":"Vaccine"},{"key":"94_CR137","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.4049\/jimmunol.0902322","volume":"184","author":"AA Chentoufi","year":"2010","unstructured":"Chentoufi, A. A. et al. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. J. Immunol. 184, 2561\u20132571 (2010).","journal-title":"J. Immunol."},{"key":"94_CR138","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/JVI.02450-15","volume":"90","author":"R Srivastava","year":"2016","unstructured":"Srivastava, R. et al. The herpes simplex virus latency-associated transcript gene is associated with a broader repertoire of virus-specific exhausted CD8+ T cells retained within the trigeminal ganglia of latently infected hla transgenic rabbits. J. Virol. 90, 3913\u20133928 (2016).","journal-title":"J. Virol."},{"key":"94_CR139","first-page":"284","volume":"41","author":"GC Perng","year":"2016","unstructured":"Perng, G. C. et al. Large amounts of reactivated virus in tears precedes recurrent herpes stromal keratitis in stressed rabbits latently infected with herpes simplex virus. Curr. Eye Res. 41, 284\u2013291 (2016).","journal-title":"Curr. Eye Res."},{"key":"94_CR140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/ICO.0000000000000666","volume":"35","author":"JV Jester","year":"2016","unstructured":"Jester, J. V. et al. Confocal microscopic analysis of a rabbit eye model of high-incidence recurrent herpes stromal keratitis. Cornea 35, 81\u201388 (2016).","journal-title":"Cornea"},{"key":"94_CR141","first-page":"2232","volume":"194","author":"R Srivastava","year":"2015","unstructured":"Srivastava, R. et al. Herpes simplex virus type 1 human asymptomatic CD8 T cell epitopes protect against ocular herpes in \u201chumanized\u201d HLA transgenic rabbit model. IOVS 194, 2232\u20132248 (2015).","journal-title":"IOVS"},{"key":"94_CR142","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1167\/iovs.15-17074","volume":"56","author":"R Srivastava","year":"2015","unstructured":"Srivastava, R. et al. A herpes simplex virus type 1 human asymptomatic CD8+ T-cell epitopes-based vaccine protects against ocular herpes in a \u201chumanized\u201d HLA transgenic rabbit model. Invest. Ophthalmol. Vis. Sci. 56, 4013\u20134028 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"94_CR143","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1128\/JVI.00788-15","volume":"89","author":"AA Khan","year":"2015","unstructured":"Khan, A. A. et al. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived \u201casymptomatic\u201d human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. J. Virol. 89, 6619\u20136632 (2015).","journal-title":"J. Virol."}],"updated-by":[{"DOI":"10.1038\/s12276-019-0252-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000}}],"container-title":["Experimental & Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0094-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0094-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0094-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:04:05Z","timestamp":1693681445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0094-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":143,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1038\/s12276-018-0094-1","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under a CC BY-NC-SA License, but has now been made available under a CC BY 4.0 License.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}